{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T17:06:06Z","timestamp":1784653566524,"version":"3.55.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,9,4]],"date-time":"2019-09-04T00:00:00Z","timestamp":1567555200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"BioMarin"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Nucleic Acids"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.omtn.2019.08.025","type":"journal-article","created":{"date-parts":[[2019,9,6]],"date-time":"2019-09-06T19:14:23Z","timestamp":1567797263000},"page":"298-307","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Therapy with 2\u2032-O-Me Phosphorothioate Antisense Oligonucleotides Causes Reversible Proteinuria by Inhibiting Renal Protein Reabsorption"],"prefix":"10.1016","volume":"18","author":[{"given":"Manoe J.","family":"Janssen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom T.G.","family":"Nieskens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tessa A.M.","family":"Steevels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Caetano-Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"den Braanker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Mulder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yolanda","family":"Ponstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaun","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalinde","family":"Masereeuw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathaline","family":"den Besten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martijn J.","family":"Wilmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtn.2019.08.025_bib1","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1053\/j.ajkd.2010.09.024","article-title":"Association of long-term administration of the survivin mRNA-targeted antisense oligonucleotide LY2181308 with reversible kidney injury in a patient with metastatic melanoma","volume":"57","author":"Herrington","year":"2011","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.omtn.2019.08.025_bib2","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S1474-4422(14)70195-4","article-title":"Safety and efficacy of drisapersen for the treatment of Duchenne muscular dystrophy (DEMAND II): an exploratory, randomised, placebo-controlled phase 2 study","volume":"13","author":"Voit","year":"2014","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.omtn.2019.08.025_bib3","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.tox.2012.06.005","article-title":"Renal uptake and tolerability of a 2\u2032-O-methoxyethyl modified antisense oligonucleotide (ISIS 113715) in monkey","volume":"301","author":"Henry","year":"2012","journal-title":"Toxicology"},{"key":"10.1016\/j.omtn.2019.08.025_bib4","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.addr.2015.01.008","article-title":"Pharmacokinetics, biodistribution and cell uptake of antisense oligonucleotides","volume":"87","author":"Geary","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.omtn.2019.08.025_bib5","doi-asserted-by":"crossref","first-page":"6518","DOI":"10.1093\/nar\/gkw236","article-title":"The delivery of therapeutic oligonucleotides","volume":"44","author":"Juliano","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2019.08.025_bib6","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1177\/019262339902700306","article-title":"Evaluation of the renal effects of an antisense phosphorothioate oligodeoxynucleotide in monkeys","volume":"27","author":"Monteith","year":"1999","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.omtn.2019.08.025_bib7","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1089\/nat.2015.0598","article-title":"Comparative Renal Toxicopathology of Antisense Oligonucleotides","volume":"26","author":"Engelhardt","year":"2016","journal-title":"Nucleic Acid Ther."},{"key":"10.1016\/j.omtn.2019.08.025_bib8","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1177\/0192623317749452","article-title":"Characterizing Adversity of Lysosomal Accumulation in Nonclinical Toxicity Studies: Results from the 5th ESTP International Expert Workshop","volume":"46","author":"Lenz","year":"2018","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.omtn.2019.08.025_bib9","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1146\/annurev.pharmtox.010909.105654","article-title":"RNA targeting therapeutics: molecular mechanisms of antisense oligonucleotides as a therapeutic platform","volume":"50","author":"Bennett","year":"2010","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.omtn.2019.08.025_bib10","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/nbt.3779","article-title":"Cellular uptake and trafficking of antisense oligonucleotides","volume":"35","author":"Crooke","year":"2017","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtn.2019.08.025_bib11","series-title":"Antisense Drug Technology: Principles, Strategies, and Applications Second Edition","first-page":"327","article-title":"Toxicologic properties of 2\u2032-O-methoxyethyl chimeric antisense inhibitors in animals and man","author":"Henry","year":"2007"},{"key":"10.1016\/j.omtn.2019.08.025_bib12","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1124\/dmd.106.009555","article-title":"Intravenously administered short interfering RNA accumulates in the kidney and selectively suppresses gene function in renal proximal tubules","volume":"34","author":"van de Water","year":"2006","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.omtn.2019.08.025_bib13","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1089\/oli.1.1998.8.67","article-title":"Cellular uptake properties of oligonucleotides in LLC-PK1 renal epithelial cells","volume":"8","author":"Takakura","year":"1998","journal-title":"Antisense Nucleic Acid Drug Dev."},{"key":"10.1016\/j.omtn.2019.08.025_bib14","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.nmd.2016.11.013","article-title":"Comparison of ambulatory capacity and disease progression of Duchenne muscular dystrophy subjects enrolled in the drisapersen DMD114673 study with a matched natural history cohort of subjects on daily corticosteroids","volume":"27","author":"Goemans","year":"2017","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.omtn.2019.08.025_bib15","doi-asserted-by":"crossref","first-page":"e0164684","DOI":"10.1371\/journal.pone.0164684","article-title":"Individualized Prediction of Changes in 6-Minute Walk Distance for Patients with Duchenne Muscular Dystrophy","volume":"11","author":"Goemans","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1016\/j.omtn.2019.08.025_bib16","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1021\/acs.molpharmaceut.5b00821","article-title":"Fluorescence-Based Transport Assays Revisited in a Human Renal Proximal Tubule Cell Line","volume":"13","author":"Caetano-Pinto","year":"2016","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.omtn.2019.08.025_bib17","doi-asserted-by":"crossref","first-page":"7014","DOI":"10.1073\/pnas.1302063110","article-title":"Receptor-mediated endocytosis and endosomal acidification is impaired in proximal tubule epithelial cells of Dent disease patients","volume":"110","author":"Gorvin","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2019.08.025_bib18","doi-asserted-by":"crossref","first-page":"26715","DOI":"10.1038\/srep26715","article-title":"Bioengineered kidney tubules efficiently excrete uremic toxins","volume":"6","author":"Jansen","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtn.2019.08.025_bib19","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.yexcr.2014.02.011","article-title":"A morphological and functional comparison of proximal tubule cell lines established from human urine and kidney tissue","volume":"323","author":"Jansen","year":"2014","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.omtn.2019.08.025_bib20","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s00441-009-0882-y","article-title":"Novel conditionally immortalized human proximal tubule cell line expressing functional influx and efflux transporters","volume":"339","author":"Wilmer","year":"2010","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.omtn.2019.08.025_bib21","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1124\/dmd.118.080721","article-title":"Recellularized Native Kidney Scaffolds as a Novel Tool in Nephrotoxicity Screening","volume":"46","author":"Fedecostante","year":"2018","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.omtn.2019.08.025_bib22","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.1007\/s00204-018-2284-y","article-title":"A novel multi-parametric high content screening assay in ciPTEC-OAT1 to predict drug-induced nephrotoxicity during drug discovery","volume":"92","author":"Sj\u00f6gren","year":"2018","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.omtn.2019.08.025_bib23","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1208\/s12248-018-0247-0","article-title":"Screening of Drug-Transporter Interactions in a 3D Microfluidic Renal Proximal Tubule on a Chip","volume":"20","author":"Vriend","year":"2018","journal-title":"AAPS J."},{"key":"10.1016\/j.omtn.2019.08.025_bib24","first-page":"97","article-title":"Laboratory measurement of urine albumin and urine total protein in screening for proteinuria in chronic kidney disease","volume":"32","author":"Martin","year":"2011","journal-title":"Clin. Biochem. Rev."},{"key":"10.1016\/j.omtn.2019.08.025_bib25","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1056\/NEJMoa1011367","article-title":"Systemic administration of PRO051 in Duchenne\u2019s muscular dystrophy","volume":"364","author":"Goemans","year":"2011","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.omtn.2019.08.025_bib26","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/nrm778","article-title":"Megalin and cubilin: multifunctional endocytic receptors","volume":"3","author":"Christensen","year":"2002","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.omtn.2019.08.025_bib27","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/S0002-9440(10)65238-8","article-title":"Megalin knockout mice as an animal model of low molecular weight proteinuria","volume":"155","author":"Leheste","year":"1999","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.omtn.2019.08.025_bib28","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1681\/ASN.V112191","article-title":"Receptor-associated protein is important for normal processing of megalin in kidney proximal tubules","volume":"11","author":"Birn","year":"2000","journal-title":"J.\u00a0Am. Soc. Nephrol."},{"key":"10.1016\/j.omtn.2019.08.025_bib29","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1002\/j.1460-2075.1996.tb00623.x","article-title":"RAP, a specialized chaperone, prevents ligand-induced ER retention and degradation of LDL receptor-related endocytic receptors","volume":"15","author":"Willnow","year":"1996","journal-title":"EMBO J."},{"key":"10.1016\/j.omtn.2019.08.025_bib30","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1146\/annurev-physiol-022516-034234","article-title":"Receptor-Mediated Endocytosis in the Proximal Tubule","volume":"79","author":"Eshbach","year":"2017","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.omtn.2019.08.025_bib31","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/BF00550876","article-title":"Receptor-mediated endocytosis of albumin in cultured opossum kidney cells: a model for proximal tubular protein reabsorption","volume":"418","author":"Schwegler","year":"1991","journal-title":"Pflugers Arch."},{"key":"10.1016\/j.omtn.2019.08.025_bib32","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1046\/j.1523-1755.2000.00314.x","article-title":"Cubilin- and megalin-mediated uptake of albumin in cultured proximal tubule cells of opossum kidney","volume":"58","author":"Zhai","year":"2000","journal-title":"Kidney Int."},{"key":"10.1016\/j.omtn.2019.08.025_bib33","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.cccn.2004.03.037","article-title":"Alpha 1-microglobulin: clinical laboratory aspects and applications","volume":"346","author":"Penders","year":"2004","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.omtn.2019.08.025_bib34","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.nmd.2015.01.005","article-title":"Renal function in children and adolescents with Duchenne muscular dystrophy","volume":"25","author":"Braat","year":"2015","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.omtn.2019.08.025_bib35","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/B978-0-12-407676-1.00002-0","article-title":"Biological activity and biotechnological aspects of locked nucleic acids","volume":"82","author":"Lundin","year":"2013","journal-title":"Adv. Genet."},{"key":"10.1016\/j.omtn.2019.08.025_bib36","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1177\/0192623313505781","article-title":"Species-specific inflammatory responses as a primary component for the development of glomerular lesions in mice and monkeys following chronic administration of a second-generation antisense oligonucleotide","volume":"42","author":"Frazier","year":"2014","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.omtn.2019.08.025_bib37","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.kint.2015.11.007","article-title":"Megalin and cubilin in proximal tubule protein reabsorption: from experimental models to human disease","volume":"89","author":"Nielsen","year":"2016","journal-title":"Kidney Int."},{"key":"10.1016\/j.omtn.2019.08.025_bib38","doi-asserted-by":"crossref","first-page":"4375","DOI":"10.1093\/nar\/gkz214","article-title":"Differential uptake, kinetics and mechanisms of intracellular trafficking of next-generation antisense oligonucleotides across human cancer cell lines","volume":"47","author":"Linnane","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2019.08.025_bib39","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1093\/nar\/gkw112","article-title":"Stabilin-1 and Stabilin-2 are specific receptors for the cellular internalization of phosphorothioate-modified antisense oligonucleotides (ASOs) in the liver","volume":"44","author":"Miller","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2019.08.025_bib40","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1089\/oli.2009.0211","article-title":"The biological effect of an antisense oligonucleotide depends on its route of endocytosis and trafficking","volume":"20","author":"Alam","year":"2010","journal-title":"Oligonucleotides"},{"key":"10.1016\/j.omtn.2019.08.025_bib41","doi-asserted-by":"crossref","first-page":"4795","DOI":"10.1093\/nar\/gkr089","article-title":"Mechanisms of single-stranded phosphorothioate modified antisense oligonucleotide accumulation in hepatocytes","volume":"39","author":"Koller","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2019.08.025_bib42","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1089\/oli.1.1996.6.177","article-title":"Uptake characteristics of oligonucleotides in the isolated rat liver perfusion system","volume":"6","author":"Takakura","year":"1996","journal-title":"Antisense Nucleic Acid Drug Dev."},{"key":"10.1016\/j.omtn.2019.08.025_bib43","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1517\/17425255.2013.737320","article-title":"Clinical pharmacokinetics of second generation antisense oligonucleotides","volume":"9","author":"Yu","year":"2013","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.omtn.2019.08.025_bib44","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1089\/ard.1995.5.279","article-title":"Renal disposition characteristics of oligonucleotides modified at terminal linkages in the perfused rat kidney","volume":"5","author":"Sawai","year":"1995","journal-title":"Antisense Res. Dev."},{"key":"10.1016\/j.omtn.2019.08.025_bib45","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.bjid.2015.05.004","article-title":"Urine alpha1-microglobulin is a better marker for early tubular dysfunction than beta2-microglobulin among tenofovir-exposed human immunodeficiency virus-infected men who have sex with men","volume":"19","author":"Kang","year":"2015","journal-title":"Braz. J. Infect. Dis."},{"key":"10.1016\/j.omtn.2019.08.025_bib46","doi-asserted-by":"crossref","first-page":"e148","DOI":"10.1038\/mtna.2014.1","article-title":"The Dynamics of Compound, Transcript, and Protein Effects After Treatment With 2OMePS Antisense Oligonucleotides in mdx Mice","volume":"3","author":"Verhaart","year":"2014","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2019.08.025_bib47","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1208\/s12248-016-9871-8","article-title":"A Human Renal Proximal Tubule Cell Line with Stable Organic Anion Transporter 1 and 3 Expression Predictive for Antiviral-Induced Toxicity","volume":"18","author":"Nieskens","year":"2016","journal-title":"AAPS J."}],"container-title":["Molecular Therapy Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253119302446?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253119302446?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T16:39:29Z","timestamp":1784651969000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2162253119302446"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":47,"alternative-id":["S2162253119302446"],"URL":"https:\/\/doi.org\/10.1016\/j.omtn.2019.08.025","relation":{},"ISSN":["2162-2531"],"issn-type":[{"value":"2162-2531","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapy with 2\u2032-O-Me Phosphorothioate Antisense Oligonucleotides Causes Reversible Proteinuria by Inhibiting Renal Protein Reabsorption","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Nucleic Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtn.2019.08.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors.","name":"copyright","label":"Copyright"}]}}